Article info
Section 1: Introductory statements and governance
1ISG-016 Evaluation of substitution and switch to etanercept biosimilar and related cost savings
Citation
1ISG-016 Evaluation of substitution and switch to etanercept biosimilar and related cost savings
Publication history
- First published March 2, 2018.
Online issue publication
April 21, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions